In June of 2023, Techdow USA Inc., a division of the Hepalink Group, successfully launched Enoxaparin Sodium (Enoxaparin) in multiple strengths of pre-filled syringes. Techdow USA’s Enoxaparin is critically needed and will be used primarily in the outpatient setting to treat and prevent harmful deep vein thrombosis and pulmonary embolisms. Techdow USA’s parent company, the Hepalink Group, is a global leader in naturally extracted active pharmaceutical ingredients (API) and finished drugs that sources from an extremely diverse and robust supply chain network. 

Techdow USA sources materials from North America, Europe, and Asia. Additionally, Hepalink Group owns and operates Scientific Protein Laboratories (SPL), the largest producer of Heparin API in North America. SPL’s API business was created by Oscar Mayer in the 1970s and is a global leader in naturally extracted API production. The Hepalink Group has expanded their worldwide offerings to now include manufacturing and marketing of their high-quality and reliable finished drug products in the USA. 

Techdow USA launched Heparin Sodium injection in 2022 followed by their next launch of Enoxaparin Sodium injection. Both Enoxaparin and Heparin Sodium are a complement to the Hepalink Group’s sophisticated vertically integrated products supply chain that provides increased supply reliability, competitive pricing, and robust quality. 

The Hepalink Group, a global supplier to the market and trusted partner to the largest pharmaceutical companies, is delighted to provide our customers with the opportunity to directly access the market’s largest global supply of our finished drug products, Enoxaparin and Heparin. Techdow USA’s products provide patients and customers the supply reliability they demand and deserve

Techdow USA is a high-performance pharmaceutical company that is committed to quality and reliability to our patients and customers. We develop, manufacture, and sell critical FDA approved products such as Heparin and Enoxaparin Injection for use in hospital and clinical settings. We are vertically integrated in raw materials and can deliver hard to source products at a competitive price.

Techdow USA is among the fastest growing companies in our industry and are always looking for ways to improve and set a new high-performance standard. We are passionate about making a difference for patients and bringing effective medicines to market.